Fmr LLC Boosts Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

FMR LLC lifted its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 23.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,050,896 shares of the construction company's stock after purchasing an additional 773,647 shares during the quarter. FMR LLC owned 4.94% of Aspen Aerogels worth $112,169,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of ASPN. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Aspen Aerogels by 10.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company's stock worth $341,000 after purchasing an additional 1,339 shares during the last quarter. nVerses Capital LLC lifted its stake in Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company's stock valued at $161,000 after acquiring an additional 1,800 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Aspen Aerogels by 15.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company's stock valued at $257,000 after acquiring an additional 1,938 shares during the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of Aspen Aerogels in the second quarter worth approximately $84,000. Finally, Quent Capital LLC purchased a new position in shares of Aspen Aerogels during the third quarter valued at approximately $118,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on ASPN shares. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, November 13th. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Tuesday, November 12th. Benchmark reissued a "buy" rating and issued a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. TD Cowen upped their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a research report on Tuesday, August 20th. Finally, Roth Mkm dropped their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $28.70.

Aspen Aerogels Price Performance

Shares of ASPN stock traded down $0.85 on Thursday, hitting $13.49. 1,567,557 shares of the stock traded hands, compared to its average volume of 1,633,044. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of 1,350.35 and a beta of 2.11. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The firm has a 50 day simple moving average of $18.91 and a two-hundred day simple moving average of $23.59. Aspen Aerogels, Inc. has a 52 week low of $10.75 and a 52 week high of $33.15.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the firm's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 4.30% of the company's stock.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.